| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased expression of and results in increased activity of SOD2 protein] | CTD | PMID:16135673 |
| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein] | CTD | PMID:20194575 |
| (+)-alpha-tocopherol | decreases expression | EXP | | 6480464 | alpha-Tocopherol results in decreased expression of SOD2 protein | CTD | PMID:18942769 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of SOD2 protein | CTD | PMID:20446108 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [epigallocatechin gallate analog results in increased abundance of Reactive Oxygen Species] | CTD | PMID:16115949 |
| (3S,5R)-fluvastatin | multiple interactions | ISO | RGD:11330 | 6480464 | [fluvastatin co-treated with Doxorubicin] results in increased expression of SOD2 protein | CTD | PMID:19147586 |
| (R)-adrenaline | multiple interactions | ISO | RGD:730872 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Epinephrine results in increased activity of SOD2 protein]; more ... | CTD | PMID:11163531 |
| (R)-adrenaline | multiple interactions | EXP | | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of SOD2 protein | CTD | PMID:19464573 |
| (R)-adrenaline | increases expression | EXP | | 6480464 | Epinephrine results in increased expression of SOD2 protein | CTD | PMID:19464573 |
| (R)-adrenaline | increases expression | ISO | RGD:730872 | 6480464 | Epinephrine results in increased expression of SOD2 mRNA; more ... | CTD | PMID:11163531 |
| (R)-adrenaline | increases activity | ISO | RGD:730872 | 6480464 | Epinephrine results in increased activity of SOD2 protein | CTD | PMID:11163531 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in decreased activity of SOD2 protein] | CTD | PMID:19951573 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [sodium arsenite results in decreased activity of SOD2 protein] | CTD | PMID:15804455 |
| (R)-noradrenaline | decreases expression | EXP | | 6480464 | Norepinephrine results in decreased expression of SOD2 protein | CTD | PMID:19168439 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | SHC1 protein affects the reaction [Norepinephrine results in decreased expression of SOD2 protein] | CTD | PMID:19168439 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of SOD2 protein | CTD | PMID:18343235 |
| (S)-nicotine | decreases expression | ISO | RGD:11330 | 6480464 | Nicotine results in decreased expression of SOD2 protein | CTD | PMID:22687363 |
| (S)-nicotine | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Nicotine results in decreased expression of SOD2 protein] | CTD | PMID:22687363 |
| 1,1'-azobis(N,N-dimethylformamide) | increases expression | ISO | RGD:730872 | 6480464 | Diamide results in increased expression of SOD2 mRNA | CTD | PMID:8760145 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | multiple interactions | EXP | | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:14996425 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | multiple interactions | EXP | | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Doxorubicin results in increased expression of SOD2 protein] | CTD | PMID:19286953 |
| 1,10-phenanthroline | multiple interactions | ISO | RGD:730872 | 6480464 | 1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein] | CTD | PMID:20674559 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:730872 | 6480464 | Dinitrochlorobenzene results in increased expression of SOD2 mRNA | CTD | PMID:20566472 PMID:16314067 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:730872 | 6480464 | Dinitrochlorobenzene results in increased expression of SOD2 mRNA | CTD | PMID:16314067 PMID:20566472 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11330 | 6480464 | [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SOD2 protein | CTD | PMID:19679656 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:11330 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SOD2 protein | CTD | PMID:19679656 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SOD2 mRNA | CTD | PMID:12883083 |
| 11-deoxycorticosterone | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; more ... | CTD | PMID:22431579 |
| 11-deoxycorticosterone | multiple interactions | EXP | | 6480464 | SOD2 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein] | CTD | PMID:11834524 |
| 11-deoxycorticosterone | decreases expression | EXP | | 6480464 | Desoxycorticosterone results in decreased expression of SOD2 protein | CTD | PMID:11834524 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:11330 | 6480464 | Ethinyl Estradiol affects the expression of SOD2 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SOD2 mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:11330 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOD2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:11330 | 6480464 | Ethinyl Estradiol results in increased expression of SOD2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | affects expression | ISO | RGD:11330 | 6480464 | Estradiol affects the expression of SOD2 mRNA | CTD | PMID:16195479 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased activity of SOD2 protein] | CTD | PMID:21966433 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of SOD2 protein | CTD | PMID:21966433 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOD2 protein | CTD | PMID:21484412 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:730872 | 6480464 | Estradiol results in increased expression of SOD2 mRNA | CTD | PMID:23019147 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol results in increased expression of and results in increased activity of SOD2 protein; more ... | CTD | PMID:12816884 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOD2 mRNA | CTD | PMID:12816884 PMID:16195479 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730872 | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased expression of SOD2 mRNA; more ... | CTD | PMID:12093828 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOD2 protein | CTD | PMID:21484412 PMID:22070562 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | KLF4 protein affects the reaction [Estradiol results in increased expression of SOD2] | CTD | PMID:21484412 |
| 17beta-estradiol | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the reaction [Estradiol deficiency results in increased expression of MKI67 protein] | CTD | PMID:21484412 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOD2 protein | CTD | PMID:22070562 PMID:21484412 |
| 17beta-estradiol | affects response to substance | EXP | | 6480464 | SOD2 protein affects the susceptibility to Estradiol | CTD | PMID:21484412 |
| 17beta-estradiol | affects response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to Estradiol | CTD | PMID:21484412 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of SOD2 mRNA] | CTD | PMID:16195479 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOD2 mRNA | CTD | PMID:16195479 |
| 17beta-estradiol | multiple interactions | ISO | RGD:11330 | 6480464 | Estradiol inhibits the reaction [Progesterone results in decreased expression of SOD2 mRNA] | CTD | PMID:16195479 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases activity | ISO | RGD:11330 | 6480464 | Dihydrotestosterone results in decreased activity of SOD2 protein | CTD | PMID:16682413 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:11330 | 6480464 | Dihydrotestosterone results in decreased expression of and results in decreased activity of SOD2 protein | CTD | PMID:16682413 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | EXP | | 6480464 | Dihydrotestosterone inhibits the reaction [Testosterone deficiency results in increased expression of SOD2 mRNA] | CTD | PMID:20850791 |
| 1H-pyrazole | decreases expression | ISO | RGD:11330 | 6480464 | pyrazole results in decreased expression of SOD2 mRNA | CTD | PMID:17945193 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | multiple interactions | EXP | | 6480464 | nebivolol inhibits the reaction [Daunorubicin results in decreased secretion of SOD2 protein] | CTD | PMID:18194856 |
| 2,2,2-tetramine | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein] | CTD | PMID:19634143 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:730872 | 6480464 | Trientine results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:14513838 |
| 2,3,2-tetramine | increases expression | ISO | RGD:730872 | 6480464 | 2,3,2-tetramine results in increased expression of SOD2 protein | CTD | PMID:15388883 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730872 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOD2 mRNA | CTD | PMID:16039398 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730872 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOD2 mRNA | CTD | PMID:16039398 PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11330 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOD2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOD2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOD2 protein | CTD | PMID:16548065 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOD2 mRNA | CTD | PMID:12225545 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:11330 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOD2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11330 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOD2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:11330 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of SOD2 mRNA] | CTD | PMID:15667827 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:730872 | 6480464 | [Butylated Hydroxyanisole co-treated with Butylated Hydroxytoluene] results in decreased expression of SOD2 mRNA | CTD | PMID:14981915 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein; more ... | CTD | PMID:17761372 |
| 2-methoxy-17beta-estradiol | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to 2-methoxyestradiol | CTD | PMID:17895890 |
| 2-methoxy-17beta-estradiol | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased susceptibility to 2-methoxyestradiol | CTD | PMID:22547077 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:730872 | 6480464 | WNT5A protein affects the reaction [[Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] which results in increased expression of SOD2 mRNA] | CTD | PMID:20685861 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | affects expression | ISO | RGD:11330 | 6480464 | Puromycin Aminonucleoside affects the expression of SOD2 protein | CTD | PMID:19264907 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | decreases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in decreased expression of SOD2 protein | CTD | PMID:19264907 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of SOD2 protein | CTD | PMID:1942778 |
| 3,3',5'-triiodothyronine | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased expression of and results in increased activity of SOD2 protein] | CTD | PMID:16135673 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:11330 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SOD2 mRNA | CTD | PMID:16054899 |
| 3-nitropropanoic acid | decreases expression | EXP | | 6480464 | 3-nitropropionic acid results in decreased expression of SOD2 mRNA | CTD | PMID:17672854 |
| 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of SOD2 mRNA] | CTD | PMID:17672854 |
| 4'-epidoxorubicin | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Epirubicin | CTD | PMID:9569045 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:11330 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of SOD2 mRNA | CTD | PMID:19191707 |
| 4-hydroxynon-2-enal | affects binding | ISO | RGD:730872 | 6480464 | 4-hydroxy-2-nonenal binds to SOD2 protein | CTD | PMID:19374891 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal] | CTD | PMID:11507057 |
| 4-hydroxynon-2-enal | decreases abundance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased abundance of 4-hydroxy-2-nonenal | CTD | PMID:11507057 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:730872 | 6480464 | decitabine results in increased expression of SOD2 protein | CTD | PMID:19294695 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:730872 | 6480464 | decitabine results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:17965603 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:730872 | 6480464 | decitabine results in increased expression of SOD2 mRNA | CTD | PMID:17965603 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:730872 | 6480464 | [trichostatin A co-treated with decitabine] results in increased expression of SOD2 protein | CTD | PMID:19294695 |
| 5-fluorouracil | multiple interactions | ISO | RGD:730872 | 6480464 | [irinotecan co-treated with Fluorouracil] results in increased activity of SOD2 protein | CTD | PMID:15886469 |
| 6alpha-methylprednisolone | multiple interactions | EXP | | 6480464 | [Methylprednisolone co-treated with Puromycin Aminonucleoside] results in increased activity of SOD2 protein | CTD | PMID:1942778 |
| 6alpha-methylprednisolone | increases activity | EXP | | 6480464 | Methylprednisolone results in increased activity of SOD2 protein | CTD | PMID:1942778 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:730872 | 6480464 | [[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter] | CTD | PMID:22009531 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal]; more ... | CTD | PMID:11507057 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:11330 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in decreased expression of SOD2 mRNA; more ... | CTD | PMID:22009531 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:730872 | 6480464 | [[[9,10-Dimethyl-1,2-benzanthracene co-treated with 12-O-tetradecanoylphorbol-1,3-acetate] results in increased activity of TRP53 protein] inhibits the reaction [SP1 protein binds to SOD2 promoter]] which results in decreased expression of SOD2 mRNA | CTD | PMID:22009531 PMID:22009531 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | RGD:11330 | 6480464 | Uric Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SOD2 protein] | CTD | PMID:21767162 |
| 7H-xanthine | multiple interactions | EXP | | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of SOD2 protein | CTD | PMID:19464573 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:730872 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 protein; more ... | CTD | PMID:16709600 |
| 8-bromo-3',5'-cyclic GMP | increases expression | EXP | | 6480464 | 8-bromocyclic GMP results in increased expression of SOD2 protein; more ... | CTD | PMID:14996425 |
| 9H-xanthine | multiple interactions | EXP | | 6480464 | [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of SOD2 protein | CTD | PMID:19464573 |
| AACOCF3 | multiple interactions | ISO | RGD:730872 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [TNF protein results in increased expression of SOD2] | CTD | PMID:11264281 |
| acetylcholine | multiple interactions | ISO | RGD:11330 | 6480464 | Indomethacin affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine]; more ... | CTD | PMID:20304815 |
| acetylcholine | affects response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to Acetylcholine | CTD | PMID:20304815 |
| acetylsalicylic acid | decreases expression | ISO | RGD:11330 | 6480464 | Aspirin results in decreased expression of SOD2 mRNA | CTD | PMID:21353610 |
| actinomycin D | multiple interactions | ISO | RGD:730872 | 6480464 | Dactinomycin inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA] | CTD | PMID:12031898 |
| actinomycin D | multiple interactions | ISO | RGD:11330 | 6480464 | Dactinomycin inhibits the reaction [krestin results in increased expression of SOD2] | CTD | PMID:11154046 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA] | CTD | PMID:14996425 |
| actinomycin D | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] | CTD | PMID:11880364 |
| actinomycin D | multiple interactions | ISO | RGD:730872 | 6480464 | Dactinomycin inhibits the reaction [SOD2 protein results in increased expression of SOD2 mRNA] | CTD | PMID:15683720 PMID:15683720 |
| albendazole | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Albendazole | CTD | PMID:19501153 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 mRNA | CTD | PMID:16249480 PMID:17169568 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 mRNA | CTD | PMID:16249480 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 mRNA | CTD | PMID:17169568 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:730872 | 6480464 | [SN50 peptide affects the localization of [RELA protein binds to NFKB1 protein]] inhibits the reaction [Tretinoin results in increased expression of SOD2 protein]; more ... | CTD | PMID:18280257 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 mRNA | CTD | PMID:16249480 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 mRNA | CTD | PMID:17169568 PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:730872 | 6480464 | Tretinoin results in increased expression of SOD2 protein | CTD | PMID:17169568 |
| alpha-hexylcinnamaldehyde | increases expression | ISO | RGD:730872 | 6480464 | hexyl cinnamic aldehyde results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| aluminium atom | decreases activity | EXP | | 6480464 | Aluminum results in decreased activity of SOD2 protein | CTD | PMID:19010380 |
| aluminium(0) | decreases activity | EXP | | 6480464 | Aluminum results in decreased activity of SOD2 protein | CTD | PMID:19010380 |
| aminoacetone | multiple interactions | EXP | | 6480464 | [aminoacetone co-treated with Copper] results in increased expression of SOD2 mRNA | CTD | PMID:18729331 |
| aminoguanidine | multiple interactions | ISO | RGD:11330 | 6480464 | pimagedine inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:18483403 |
| aminoguanidine | decreases expression | ISO | RGD:730872 | 6480464 | pimagedine results in decreased expression of SOD2 protein | CTD | PMID:19266598 |
| amiodarone | increases expression | ISO | RGD:730872 | 6480464 | Amiodarone results in increased expression of SOD2 mRNA | CTD | PMID:23135547 |
| ammonium acetate | decreases activity | EXP | | 6480464 | ammonium acetate results in decreased activity of SOD2 protein | CTD | PMID:12885441 |
| ammonium acetate | multiple interactions | EXP | | 6480464 | Dizocilpine Maleate inhibits the reaction [ammonium acetate results in decreased activity of SOD2 protein] | CTD | PMID:12885441 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SOD2 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of SOD2 protein | CTD | PMID:12420312 |
| amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SOD2 mRNA | CTD | PMID:16084549 |
| antimycin A | multiple interactions | ISO | RGD:730872 | 6480464 | Antimycin A inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] | CTD | PMID:11264281 |
| antimycin A | multiple interactions | EXP | | 6480464 | Antimycin A inhibits the reaction [Lipopolysaccharides results in increased expression of SOD2 mRNA] | CTD | PMID:11264281 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein] | CTD | PMID:22431579 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Formaldehyde results in increased expression of SOD2 mRNA] | CTD | PMID:21983654 |
| arachidonic acid | increases expression | ISO | RGD:730872 | 6480464 | Arachidonic Acid results in increased expression of SOD2 mRNA | CTD | PMID:12031898 |
| arachidonic acid | increases activity | EXP | | 6480464 | Arachidonic Acid results in increased activity of SOD2 protein | CTD | PMID:16982041 |
| arachidonic acid | multiple interactions | EXP | | 6480464 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [Arachidonic Acid results in increased activity of SOD2 protein]; more ... | CTD | PMID:16982041 |
| arachidonic acid | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:12031898 |
| arsenic atom | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene polymorphism affects the susceptibility to Arsenic | CTD | PMID:16076760 |
| arsenic atom | decreases expression | ISO | RGD:11330 | 6480464 | Arsenic results in decreased expression of SOD2 protein | CTD | PMID:22552367 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of SOD2 mRNA | CTD | PMID:22434702 |
| arsenic atom | affects expression | ISO | RGD:730872 | 6480464 | Arsenic affects the expression of SOD2 | CTD | PMID:21235219 |
| arsenic atom | increases expression | ISO | RGD:730872 | 6480464 | Arsenic results in increased expression of SOD2 mRNA | CTD | PMID:19945496 |
| arsenic atom | decreases expression | ISO | RGD:730872 | 6480464 | Arsenic results in decreased expression of SOD2 mRNA | CTD | PMID:16835338 |
| arsenite(3-) | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased susceptibility to arsenite | CTD | PMID:9548797 |
| astemizole | increases expression | EXP | | 6480464 | Astemizole results in increased expression of SOD2 mRNA | CTD | PMID:20221588 |
| atenolol | multiple interactions | ISO | RGD:730872 | 6480464 | Atenolol inhibits the reaction [Epinephrine results in increased activity of SOD2 protein] | CTD | PMID:11163531 |
| ATP | affects chemical synthesis | ISO | RGD:11330 | 6480464 | SOD2 protein affects the chemical synthesis of Adenosine Triphosphate | CTD | PMID:20638473 |
| atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of SOD2 mRNA | CTD | PMID:23132811 |
| azathioprine | increases expression | ISO | RGD:730872 | 6480464 | Azathioprine results in increased expression of SOD2 mRNA | CTD | PMID:18222062 |
| Bandrowski's base | increases expression | ISO | RGD:730872 | 6480464 | Bandrowski's base results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11330 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of SOD2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:730872 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of SOD2 protein] | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | ISO | RGD:730872 | 6480464 | Benzo(a)pyrene results in increased expression of SOD2 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730872 | 6480464 | Benzo(a)pyrene results in decreased expression of SOD2 protein | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | ISO | RGD:11330 | 6480464 | Benzo(a)pyrene results in increased expression of SOD2 mRNA | CTD | PMID:22228805 |
| beta-carotene | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 mRNA]; more ... | CTD | PMID:18779489 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:11330 | 6480464 | Mustard Gas results in increased expression of SOD2 mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | decreases activity | ISO | RGD:11330 | 6480464 | Mustard Gas results in decreased activity of SOD2 protein | CTD | PMID:19560481 |
| bisphenol A | decreases expression | ISO | RGD:730872 | 6480464 | bisphenol A results in decreased expression of SOD2 mRNA | CTD | PMID:22576693 |
| bisphenol A | increases methylation | ISO | RGD:730872 | 6480464 | bisphenol A results in increased methylation of SOD2 gene | CTD | PMID:22576693 |
| bucladesine | increases expression | ISO | RGD:730872 | 6480464 | Bucladesine results in increased expression of SOD2 mRNA | CTD | PMID:20685861 |
| bucladesine | increases expression | ISO | RGD:730872 | 6480464 | Bucladesine results in increased expression of SOD2 mRNA | CTD | PMID:12093828 PMID:20685861 |
| bucladesine | increases activity | ISO | RGD:730872 | 6480464 | Bucladesine results in increased activity of SOD2 protein | CTD | PMID:12093828 |
| bucladesine | increases expression | ISO | RGD:730872 | 6480464 | Bucladesine results in increased expression of SOD2 mRNA | CTD | PMID:20685861 PMID:12093828 |
| bucladesine | multiple interactions | ISO | RGD:730872 | 6480464 | protein kinase inhibitor peptide inhibits the reaction [Bucladesine results in increased activity of SOD2 protein] | CTD | PMID:12093828 |
| bucladesine | multiple interactions | ISO | RGD:730872 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Bucladesine results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:20685861 |
| butyric acid | decreases activity | ISO | RGD:730872 | 6480464 | Butyric Acid results in decreased activity of SOD2 protein | CTD | PMID:10656287 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of SOD2 mRNA | CTD | PMID:19167457 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of SOD2 mRNA | CTD | PMID:20471445 |
| cadmium atom | decreases activity | EXP | | 6480464 | Cadmium results in decreased activity of SOD2 protein | CTD | PMID:22127830 |
| cadmium atom | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein inhibits the reaction [Cadmium results in increased phosphorylation of STK11 protein] | CTD | PMID:21767558 |
| cadmium dichloride | decreases activity | ISO | RGD:11330 | 6480464 | Cadmium Chloride results in decreased activity of SOD2 protein | CTD | PMID:15964310 |
| cadmium dichloride | increases activity | ISO | RGD:730872 | 6480464 | Cadmium Chloride results in increased activity of SOD2 protein | CTD | PMID:21040778 |
| cadmium dichloride | decreases expression | ISO | RGD:11330 | 6480464 | Cadmium Chloride results in decreased expression of SOD2 mRNA | CTD | PMID:11958953 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Manganese inhibits the reaction [Cadmium Chloride results in decreased activity of SOD2 protein] | CTD | PMID:12204541 |
| cadmium dichloride | decreases activity | EXP | | 6480464 | Cadmium Chloride results in decreased activity of SOD2 protein | CTD | PMID:12204541 |
| cadmium dichloride | increases expression | ISO | RGD:730872 | 6480464 | Cadmium Chloride results in increased expression of SOD2 mRNA | CTD | PMID:12160620 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SOD2 mRNA | CTD | PMID:20107868 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SOD2 protein | CTD | PMID:17098586 PMID:21699967 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of SOD2 mRNA | CTD | PMID:21442002 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SOD2 protein | CTD | PMID:17098586 |
| cadmium sulfate | increases expression | ISO | RGD:730872 | 6480464 | cadmium sulfate results in increased expression of SOD2 mRNA | CTD | PMID:12064557 |
| capsaicin | increases expression | ISO | RGD:11330 | 6480464 | Capsaicin results in increased expression of SOD2 protein modified form | CTD | PMID:19129394 |
| capsaicin | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 results in decreased susceptibility to Capsaicin | CTD | PMID:19129394 |
| capsaicin | multiple interactions | ISO | RGD:11330 | 6480464 | phenyl-N-tert-butylnitrone inhibits the reaction [Capsaicin results in decreased activity of SOD2 protein]; more ... | CTD | PMID:19129394 |
| carbamazepine | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Carbamazepine | CTD | PMID:19501153 |
| carbon monoxide | multiple interactions | ISO | RGD:11330 | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | CTD | PMID:18037988 |
| carbon monoxide | increases expression | EXP | | 6480464 | Carbon Monoxide results in increased expression of SOD2 protein | CTD | PMID:17179207 |
| carbon monoxide | multiple interactions | ISO | RGD:11330 | 6480464 | NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of SOD2 mRNA] | CTD | PMID:18845810 |
| carbon monoxide | increases expression | ISO | RGD:11330 | 6480464 | Carbon Monoxide results in increased expression of SOD2 mRNA | CTD | PMID:18845810 |
| carboplatin | multiple interactions | EXP | | 6480464 | Carboplatin results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:15109710 |
| carboplatin | decreases expression | EXP | | 6480464 | Carboplatin results in decreased expression of SOD2 protein | CTD | PMID:15225673 |
| carmustine | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| carmustine | decreases activity | ISO | RGD:730872 | 6480464 | Carmustine results in decreased activity of SOD2 protein | CTD | PMID:19856331 |
| carotenoid | multiple interactions | ISO | RGD:11330 | 6480464 | [[BCO2 gene mutant form results in decreased metabolism of Carotenoids] which results in increased abundance of Carotenoids] which results in increased expression of SOD2 protein | CTD | PMID:21106934 |
| carotenoid | increases expression | ISO | RGD:11330 | 6480464 | Carotenoids results in increased expression of SOD2 protein | CTD | PMID:21106934 |
| celecoxib | decreases expression | ISO | RGD:730872 | 6480464 | celecoxib results in decreased expression of SOD2 protein | CTD | PMID:18848576 |
| cerium trichloride | decreases activity | ISO | RGD:11330 | 6480464 | cerous chloride results in decreased activity of SOD2 protein | CTD | PMID:15964310 |
| chlorobenzene | increases expression | ISO | RGD:730872 | 6480464 | chlorobenzene results in increased expression of SOD2 mRNA | CTD | PMID:19800902 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of SOD2 mRNA | CTD | PMID:19440498 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of SOD2 mRNA | CTD | PMID:20691718 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of SOD2 protein | CTD | PMID:22714038 |
| chlorpyrifos | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD2 protein] | CTD | PMID:22714038 |
| chromium atom | increases expression | ISO | RGD:730872 | 6480464 | Chromium results in increased expression of SOD2 protein | CTD | PMID:19289165 |
| chromium(6+) | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to chromium hexavalent ion | CTD | PMID:21742780 |
| chromium(6+) | decreases expression | ISO | RGD:11330 | 6480464 | chromium hexavalent ion results in decreased expression of SOD2 protein | CTD | PMID:22552367 |
| chrysazin | decreases expression | ISO | RGD:730872 | 6480464 | danthron results in decreased expression of SOD2 protein | CTD | PMID:21126053 |
| cinnamyl alcohol | increases expression | ISO | RGD:730872 | 6480464 | cinnamyl alcohol results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| ciprofibrate | decreases activity | EXP | | 6480464 | ciprofibrate results in decreased activity of SOD2 protein | CTD | PMID:19544052 |
| cisplatin | decreases expression | ISO | RGD:11330 | 6480464 | Cisplatin results in decreased expression of SOD2 mRNA | CTD | PMID:21570986 |
| cisplatin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Cisplatin | CTD | PMID:17523305 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SOD2 mRNA | CTD | PMID:17602206 |
| clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of SOD2 mRNA | CTD | PMID:15860345 |
| cobalt atom | decreases activity | EXP | | 6480464 | Cobalt results in decreased activity of SOD2 protein | CTD | PMID:11768320 |
| coenzyme Q10 | affects expression | EXP | | 6480464 | coenzyme Q10 affects the expression of SOD2 protein | CTD | PMID:22083459 |
| copper atom | decreases activity | EXP | | 6480464 | Copper results in decreased activity of SOD2 protein | CTD | PMID:22127830 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with Dietary Sucrose] results in decreased activity of SOD2 protein | CTD | PMID:19539026 |
| copper atom | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; more ... | CTD | PMID:18779489 |
| copper atom | multiple interactions | EXP | | 6480464 | [aminoacetone co-treated with Copper] results in increased expression of SOD2 mRNA | CTD | PMID:18729331 |
| copper(0) | decreases activity | EXP | | 6480464 | Copper results in decreased activity of SOD2 protein | CTD | PMID:22127830 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with Dietary Sucrose] results in decreased activity of SOD2 protein | CTD | PMID:19539026 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; more ... | CTD | PMID:18779489 |
| copper(0) | multiple interactions | EXP | | 6480464 | [aminoacetone co-treated with Copper] results in increased expression of SOD2 mRNA | CTD | PMID:18729331 |
| copper(2+) sulfate | decreases activity | EXP | | 6480464 | Copper Sulfate results in decreased activity of SOD2 protein | CTD | PMID:19715684 |
| copper(2+) sulfate | multiple interactions | EXP | | 6480464 | [Dopamine co-treated with Dicumarol co-treated with Copper Sulfate] results in decreased expression of SOD2 mRNA | CTD | PMID:11299314 |
| copper(2+) sulfate | increases expression | ISO | RGD:730872 | 6480464 | Copper Sulfate results in increased expression of SOD2 mRNA | CTD | PMID:19549813 |
| creatinine | decreases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased abundance of Creatinine | CTD | PMID:19917352 |
| crocidolite asbestos | increases expression | ISO | RGD:730872 | 6480464 | Asbestos, Crocidolite results in increased expression of SOD2 mRNA | CTD | PMID:18687144 |
| crocidolite asbestos | increases expression | ISO | RGD:730872 | 6480464 | Asbestos, Crocidolite results in increased expression of SOD2 mRNA | CTD | PMID:18687144 PMID:20831825 |
| crocidolite asbestos | increases expression | ISO | RGD:730872 | 6480464 | Asbestos, Crocidolite results in increased expression of SOD2 mRNA | CTD | PMID:20831825 PMID:18687144 |
| curcumin | affects expression | EXP | | 6480464 | Curcumin affects the expression of SOD2 mRNA; more ... | CTD | PMID:11543823 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Thyroxine results in decreased activity of SOD2 protein]; more ... | CTD | PMID:19914224 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of SOD2 mRNA | CTD | PMID:18299980 |
| cycloheximide | multiple interactions | ISO | RGD:11330 | 6480464 | Cycloheximide inhibits the reaction [NGF protein results in increased expression of SOD2 protein] | CTD | PMID:20495008 |
| cycloheximide | multiple interactions | ISO | RGD:11330 | 6480464 | Cycloheximide inhibits the reaction [krestin results in increased expression of SOD2] | CTD | PMID:11154046 |
| cycloheximide | increases expression | ISO | RGD:730872 | 6480464 | Cycloheximide results in increased expression of SOD2 mRNA | CTD | PMID:15330761 |
| cycloheximide | multiple interactions | ISO | RGD:730872 | 6480464 | Cycloheximide promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:15330761 |
| cyclophosphamide | increases expression | ISO | RGD:11330 | 6480464 | Cyclophosphamide results in increased expression of SOD2 mRNA | CTD | PMID:15331540 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of SOD2 mRNA | CTD | PMID:11599041 |
| cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of SOD2 mRNA | CTD | PMID:11906922 |
| cyclosporin A | increases expression | ISO | RGD:730872 | 6480464 | Cyclosporine results in increased expression of SOD2 mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | ISO | RGD:11330 | 6480464 | cypermethrin results in increased expression of SOD2 mRNA | CTD | PMID:21142847 PMID:21397294 |
| cysteamine | increases expression | EXP | | 6480464 | [Cysteamine results in increased expression of HMOX1] which results in increased expression of SOD2; more ... | CTD | PMID:10942521 |
| cysteamine | multiple interactions | EXP | | 6480464 | [stannous mesoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [Cysteamine results in increased expression of SOD2 protein] | CTD | PMID:10942521 |
| D-glucose | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; more ... | CTD | PMID:17309078 |
| D-glucose | increases expression | ISO | RGD:11330 | 6480464 | Glucose results in increased expression of SOD2 protein | CTD | PMID:23090186 |
| D-glucose | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:23090186 |
| D-glucose | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; more ... | CTD | PMID:14514642 |
| D-glucose | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Glucose | CTD | PMID:11050244 |
| D-glucose | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; more ... | CTD | PMID:11050244 |
| D-glucose | decreases expression | ISO | RGD:730872 | 6480464 | Glucose deficiency results in decreased expression of SOD2 protein | CTD | PMID:22314686 |
| D-glucose | multiple interactions | ISO | RGD:11330 | 6480464 | [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein | CTD | PMID:19429140 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SOD2 mRNA | CTD | PMID:21818840 |
| D-glucose | multiple interactions | ISO | RGD:11330 | 6480464 | pimagedine inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:18483403 |
| D-glucose | decreases expression | ISO | RGD:11330 | 6480464 | Glucose results in decreased expression of SOD2 protein | CTD | PMID:18483403 |
| D-glucose | affects folding | ISO | RGD:730872 | 6480464 | Glucose deficiency affects the folding of SOD2 protein | CTD | PMID:17309078 |
| dapsone | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Dapsone | CTD | PMID:19501153 |
| dapsone | multiple interactions | ISO | RGD:11330 | 6480464 | Dapsone inhibits the reaction [Paraquat results in decreased expression of SOD2 protein] | CTD | PMID:21765237 |
| daunorubicin | decreases secretion | EXP | | 6480464 | Daunorubicin results in decreased secretion of SOD2 protein | CTD | PMID:18194856 |
| daunorubicin | multiple interactions | EXP | | 6480464 | nebivolol inhibits the reaction [Daunorubicin results in decreased secretion of SOD2 protein] | CTD | PMID:18194856 |
| dehydroascorbic acid | multiple interactions | ISO | RGD:730872 | 6480464 | [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of SOD2 protein; more ... | CTD | PMID:20166893 |
| dehydroascorbic acid | increases expression | ISO | RGD:730872 | 6480464 | Dehydroascorbic Acid results in increased expression of SOD2 protein | CTD | PMID:20166893 |
| dehydroepiandrosterone | decreases expression | EXP | | 6480464 | Dehydroepiandrosterone results in decreased expression of SOD2 mRNA | CTD | PMID:16940010 |
| desferrioxamine B | increases expression | ISO | RGD:730872 | 6480464 | Deferoxamine results in increased expression of SOD2 protein | CTD | PMID:16927372 |
| desferrioxamine B | multiple interactions | ISO | RGD:730872 | 6480464 | TRAP1 protein inhibits the reaction [Deferoxamine results in increased expression of SOD2 protein] | CTD | PMID:16927372 |
| desferrioxamine B | multiple interactions | ISO | RGD:11330 | 6480464 | Deferoxamine inhibits the reaction [SOD2 protein affects the reaction [Ethanol results in increased abundance of Iron]] | CTD | PMID:19063909 |
| dexamethasone | multiple interactions | ISO | RGD:11330 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SOD2 mRNA | CTD | PMID:16054899 |
| dexamethasone | increases expression | ISO | RGD:730872 | 6480464 | Dexamethasone results in increased expression of SOD2 mRNA | CTD | PMID:19853017 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD2 protein]; more ... | CTD | PMID:17015168 |
| diarsenic trioxide | affects expression | ISO | RGD:730872 | 6480464 | arsenic trioxide affects the expression of SOD2 protein | CTD | PMID:18588940 |
| diarsenic trioxide | increases expression | ISO | RGD:730872 | 6480464 | arsenic trioxide results in increased expression of SOD2 mRNA | CTD | PMID:22521957 |
| diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of SOD2 mRNA | CTD | PMID:19440498 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of SOD2 mRNA | CTD | PMID:21266533 |
| dichlorvos | decreases activity | EXP | | 6480464 | Dichlorvos results in decreased activity of SOD2 protein | CTD | PMID:17850875 |
| dichlorvos | multiple interactions | EXP | | 6480464 | [10-(6'-ubiquinonyl)decyltriphenylphosphonium bromide results in increased expression of SOD2 protein] which results in decreased susceptibility to Dichlorvos | CTD | PMID:21784090 |
| diclofenac | increases expression | ISO | RGD:730872 | 6480464 | Diclofenac results in increased expression of SOD2 mRNA | CTD | PMID:19022234 |
| diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of SOD2 mRNA | CTD | PMID:19022234 |
| dicoumarol | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Dicumarol | CTD | PMID:17040906 |
| dicoumarol | multiple interactions | EXP | | 6480464 | [Dopamine co-treated with Dicumarol co-treated with Copper Sulfate] results in decreased expression of SOD2 mRNA | CTD | PMID:11299314 |
| dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of SOD2 mRNA | CTD | PMID:19440498 |
| diethylstilbestrol | increases expression | ISO | RGD:11330 | 6480464 | Diethylstilbestrol results in increased expression of SOD2 mRNA | CTD | PMID:21041162 |
| dioxygen | increases expression | ISO | RGD:730872 | 6480464 | Oxygen deficiency results in increased expression of SOD2 mRNA | CTD | PMID:17175027 |
| dioxygen | increases expression | ISO | RGD:11330 | 6480464 | Oxygen results in increased expression of SOD2 mRNA | CTD | PMID:10781441 PMID:17010595 |
| dioxygen | affects expression | EXP | | 6480464 | Oxygen deficiency affects the expression of SOD2 mRNA | CTD | PMID:17963755 |
| dioxygen | increases expression | ISO | RGD:11330 | 6480464 | Oxygen results in increased expression of SOD2 mRNA | CTD | PMID:17010595 PMID:10781441 |
| dioxygen | multiple interactions | ISO | RGD:11330 | 6480464 | TNFRSF1A protein affects the reaction [Oxygen results in increased expression of SOD2 mRNA] | CTD | PMID:10781441 |
| dioxygen | decreases activity | ISO | RGD:730872 | 6480464 | Oxygen deficiency results in decreased activity of SOD2 protein | CTD | PMID:12097231 |
| dioxygen | increases activity | EXP | | 6480464 | Oxygen results in increased activity of SOD2 protein | CTD | PMID:20812253 |
| dioxygen | increases expression | ISO | RGD:11330 | 6480464 | Oxygen results in increased expression of SOD2 mRNA; more ... | CTD | PMID:17010595 |
| dioxygen | decreases expression | ISO | RGD:11330 | 6480464 | Oxygen deficiency results in decreased expression of SOD2 mRNA | CTD | PMID:21382473 |
| dioxygen | decreases activity | ISO | RGD:11330 | 6480464 | Oxygen deficiency results in decreased activity of SOD2 protein | CTD | PMID:21382473 |
| dioxygen | multiple interactions | ISO | RGD:11330 | 6480464 | Emodin inhibits the reaction [Oxygen deficiency results in decreased activity of SOD2 protein]; more ... | CTD | PMID:21382473 |
| dioxygen | multiple interactions | ISO | RGD:11330 | 6480464 | Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 protein]; more ... | CTD | PMID:17010595 |
| dioxygen | multiple interactions | ISO | RGD:730872 | 6480464 | TXN protein promotes the reaction [Oxygen results in increased activity of SOD2 protein] | CTD | PMID:20812253 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen results in increased expression of SOD2 mRNA | CTD | PMID:15680347 |
| dioxygen | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 gene mutant form results in increased susceptibility to Oxygen | CTD | PMID:11156968 |
| dioxygen | multiple interactions | ISO | RGD:11330 | 6480464 | Oxygen affects the reaction [SOD2 gene mutant form affects the susceptibility to Paraquat]; more ... | CTD | PMID:11156968 |
| dioxygen | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Oxygen | CTD | PMID:11306437 |
| dioxygen | multiple interactions | ISO | RGD:730872 | 6480464 | CAT protein promotes the reaction [SOD2 protein results in decreased susceptibility to Oxygen] | CTD | PMID:11306437 |
| diquat | multiple interactions | ISO | RGD:11330 | 6480464 | GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; more ... | CTD | PMID:11672444 |
| diquat | increases activity | ISO | RGD:11330 | 6480464 | Diquat results in increased activity of SOD2 protein | CTD | PMID:11672444 |
| disodium selenite | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Sodium Selenite | CTD | PMID:15130278 PMID:15650415 |
| disodium selenite | increases expression | ISO | RGD:730872 | 6480464 | Sodium Selenite results in increased expression of SOD2 protein | CTD | PMID:21215776 |
| disodium selenite | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Sodium Selenite | CTD | PMID:15650415 PMID:15130278 |
| disodium selenite | decreases expression | ISO | RGD:11330 | 6480464 | Sodium Selenite results in decreased expression of SOD2 mRNA; more ... | CTD | PMID:15650415 |
| disodium selenite | multiple interactions | ISO | RGD:11330 | 6480464 | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA] | CTD | PMID:15650415 |
| disulfiram | increases expression | ISO | RGD:730872 | 6480464 | Disulfiram results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| divanadium pentaoxide | increases expression | ISO | RGD:730872 | 6480464 | vanadium pentoxide results in increased expression of SOD2 mRNA | CTD | PMID:17459161 |
| docebenone | multiple interactions | EXP | | 6480464 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [Arachidonic Acid results in increased activity of SOD2 protein] | CTD | PMID:16982041 |
| dopamine | increases expression | EXP | | 6480464 | Dopamine results in increased expression of SOD2 mRNA; more ... | CTD | PMID:10942521 |
| dopamine | decreases expression | EXP | | 6480464 | Dopamine results in decreased expression of SOD2 mRNA | CTD | PMID:11299314 |
| dopamine | multiple interactions | EXP | | 6480464 | [Dopamine co-treated with Dicumarol co-treated with Copper Sulfate] results in decreased expression of SOD2 mRNA | CTD | PMID:11299314 |
| doxorubicin | decreases activity | ISO | RGD:730872 | 6480464 | Doxorubicin results in decreased activity of SOD2 protein | CTD | PMID:10656287 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | CTD | PMID:22015447 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 protein | CTD | PMID:10912462 more ... |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 mRNA | CTD | PMID:10912462 PMID:10959798 |
| doxorubicin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:10969820 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Probucol inhibits the reaction [Doxorubicin results in decreased expression of SOD2 mRNA]; more ... | CTD | PMID:10912462 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of SOD2 protein | CTD | PMID:14736733 PMID:19286953 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 protein | CTD | PMID:16495754 more ... |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 mRNA | CTD | PMID:10959798 PMID:10912462 |
| doxorubicin | multiple interactions | ISO | RGD:730872 | 6480464 | TP53 protein affects the reaction [Doxorubicin results in increased expression of SOD2 mRNA] | CTD | PMID:15059885 |
| doxorubicin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:10969820 more ... |
| doxorubicin | increases expression | ISO | RGD:730872 | 6480464 | Doxorubicin results in increased expression of SOD2 mRNA | CTD | PMID:15059885 |
| doxorubicin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:14660625 more ... |
| doxorubicin | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:18594523 |
| doxorubicin | decreases activity | EXP | | 6480464 | Doxorubicin results in decreased activity of SOD2 protein | CTD | PMID:1940584 PMID:7655449 |
| doxorubicin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:10969820 PMID:14660625 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 protein | CTD | PMID:18400355 PMID:16495754 |
| doxorubicin | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Doxorubicin | CTD | PMID:18384434 PMID:16217747 |
| doxorubicin | multiple interactions | EXP | | 6480464 | SOD2 protein inhibits the reaction [Doxorubicin affects the localization of NFATC3 protein]; more ... | CTD | PMID:15799720 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 protein | CTD | PMID:16495754 PMID:18400355 |
| doxorubicin | multiple interactions | EXP | | 6480464 | GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | CTD | PMID:18400355 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of SOD2 protein | CTD | PMID:19286953 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOD2 mRNA | CTD | PMID:10959798 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of SOD2 mRNA | CTD | PMID:12187937 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Doxorubicin results in increased expression of SOD2 protein]; more ... | CTD | PMID:19286953 |
| doxorubicin | decreases activity | EXP | | 6480464 | Doxorubicin results in decreased activity of SOD2 protein | CTD | PMID:7655449 PMID:1940584 |
| doxorubicin | multiple interactions | ISO | RGD:11330 | 6480464 | [TRP53 protein results in decreased expression of SOD2 mRNA] which results in increased susceptibility to Doxorubicin | CTD | PMID:10969820 |
| doxorubicin | multiple interactions | ISO | RGD:11330 | 6480464 | [fluvastatin co-treated with Doxorubicin] results in increased expression of SOD2 protein | CTD | PMID:19147586 |
| doxorubicin | increases expression | ISO | RGD:11330 | 6480464 | Doxorubicin results in increased expression of SOD2 protein | CTD | PMID:19286953 |
| doxorubicin | decreases expression | ISO | RGD:11330 | 6480464 | Doxorubicin results in decreased expression of SOD2 protein | CTD | PMID:18037988 |
| doxorubicin | multiple interactions | ISO | RGD:11330 | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | CTD | PMID:18037988 |
| doxorubicin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:14660625 PMID:10969820 |
| doxorubicin | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 PMID:18384434 |
| edaravone | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [PRNP protein alternative form results in decreased activity of SOD2 protein] | CTD | PMID:20806394 |
| elemental selenium | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene polymorphism affects the susceptibility to Selenium | CTD | PMID:19528373 |
| elemental selenium | multiple interactions | ISO | RGD:730872 | 6480464 | SEPP1 gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium] | CTD | PMID:19074884 |
| elemental selenium | increases expression | ISO | RGD:730872 | 6480464 | Selenium results in increased expression of SOD2 mRNA | CTD | PMID:17293063 |
| elemental selenium | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene SNP affects the susceptibility to Selenium | CTD | PMID:19074884 |
| emodin | multiple interactions | ISO | RGD:11330 | 6480464 | Emodin inhibits the reaction [Oxygen deficiency results in decreased activity of SOD2 protein]; more ... | CTD | PMID:21382473 |
| enalapril | decreases activity | EXP | | 6480464 | Enalapril results in decreased activity of SOD2 protein | CTD | PMID:18765277 |
| enalapril | decreases expression | ISO | RGD:11330 | 6480464 | Enalapril results in decreased expression of SOD2 protein | CTD | PMID:20720404 |
| enalapril | multiple interactions | ISO | RGD:11330 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of SOD2 protein | CTD | PMID:20720404 |
| endosulfan | increases expression | ISO | RGD:11330 | 6480464 | Endosulfan results in increased expression of SOD2 mRNA | CTD | PMID:22515965 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SOD2 mRNA | CTD | PMID:10787391 |
| ethanol | increases activity | ISO | RGD:11330 | 6480464 | Ethanol results in increased activity of SOD2 protein | CTD | PMID:20016022 PMID:19063909 |
| ethanol | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the reaction [Ethanol results in increased expression of NOS2 protein] | CTD | PMID:20016022 |
| ethanol | decreases activity | ISO | RGD:11330 | 6480464 | Ethanol results in decreased activity of SOD2 protein | CTD | PMID:20016022 |
| ethanol | increases activity | ISO | RGD:11330 | 6480464 | Ethanol results in increased activity of SOD2 protein | CTD | PMID:19063909 PMID:20016022 |
| ethanol | increases expression | ISO | RGD:11330 | 6480464 | Ethanol results in increased expression of SOD2 protein | CTD | PMID:19951287 |
| ethanol | multiple interactions | ISO | RGD:11330 | 6480464 | Deferoxamine inhibits the reaction [SOD2 protein affects the reaction [Ethanol results in increased abundance of Iron]]; more ... | CTD | PMID:19063909 |
| ethanol | multiple interactions | EXP | | 6480464 | Vitamin E affects the reaction [Ethanol affects the activity of SOD2 protein] | CTD | PMID:10787391 |
| etoposide | increases expression | ISO | RGD:730872 | 6480464 | Etoposide results in increased expression of SOD2 protein | CTD | PMID:10759716 |
| etoposide | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Etoposide | CTD | PMID:10759716 |
| eugenol | increases expression | ISO | RGD:730872 | 6480464 | Eugenol results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| eugenol | decreases expression | ISO | RGD:730872 | 6480464 | Eugenol results in decreased expression of SOD2 mRNA; more ... | CTD | PMID:16101137 |
| eugenol | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; more ... | CTD | PMID:16101137 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of SOD2 mRNA | CTD | PMID:17264098 |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of SOD2 mRNA; more ... | CTD | PMID:20850791 |
| flutamide | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 results in decreased susceptibility to Flutamide | CTD | PMID:19442681 |
| flutamide | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Flutamide | CTD | PMID:19501153 |
| formaldehyde | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Formaldehyde results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:21983654 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SOD2 mRNA | CTD | PMID:21983654 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of SOD2 mRNA] | CTD | PMID:12816884 |
| genistein | multiple interactions | ISO | RGD:730872 | 6480464 | Genistein inhibits the reaction [TNF protein results in increased activity of SOD2 protein]; more ... | CTD | PMID:9372618 |
| genistein | decreases expression | ISO | RGD:730872 | 6480464 | Genistein results in decreased expression of SOD2 mRNA | CTD | PMID:20816778 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | CTD | PMID:16366677 |
| gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Cholesterol, Dietary] results in decreased expression of SOD2 protein] | CTD | PMID:14871415 |
| gliotoxin | multiple interactions | ISO | RGD:730872 | 6480464 | Gliotoxin inhibits the reaction [Lipopolysaccharides results in increased expression of SOD2 mRNA] | CTD | PMID:10653605 |
| glucose | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; more ... | CTD | PMID:17309078 |
| glucose | increases expression | ISO | RGD:11330 | 6480464 | Glucose results in increased expression of SOD2 protein | CTD | PMID:23090186 |
| glucose | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:23090186 |
| glucose | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; more ... | CTD | PMID:14514642 |
| glucose | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Glucose | CTD | PMID:11050244 |
| glucose | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Glucose results in decreased phosphorylation of SP1 protein]; more ... | CTD | PMID:11050244 |
| glucose | decreases expression | ISO | RGD:730872 | 6480464 | Glucose deficiency results in decreased expression of SOD2 protein | CTD | PMID:22314686 |
| glucose | multiple interactions | ISO | RGD:11330 | 6480464 | [Glucose co-treated with SOD2 gene mutant form] results in decreased expression of HIF1A protein | CTD | PMID:19429140 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SOD2 mRNA | CTD | PMID:21818840 |
| glucose | multiple interactions | ISO | RGD:11330 | 6480464 | pimagedine inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:18483403 |
| glucose | decreases expression | ISO | RGD:11330 | 6480464 | Glucose results in decreased expression of SOD2 protein | CTD | PMID:18483403 |
| glucose | affects folding | ISO | RGD:730872 | 6480464 | Glucose deficiency affects the folding of SOD2 protein | CTD | PMID:17309078 |
| glutathione | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Glutathione | CTD | PMID:15130278 |
| glutathione | multiple interactions | ISO | RGD:730872 | 6480464 | Glutathione affects the reaction [SOD2 protein affects the activity of CASP9 protein]; more ... | CTD | PMID:18594523 |
| glutathione | multiple interactions | ISO | RGD:730872 | 6480464 | Glutathione promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA] | CTD | PMID:16101137 |
| glutathione disulfide | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Glutathione Disulfide | CTD | PMID:15130278 |
| Goe 6976 | multiple interactions | ISO | RGD:730872 | 6480464 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:21705328 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of SOD2 mRNA | CTD | PMID:15860345 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of SOD2 protein | CTD | PMID:16564057 |
| haloperidol | multiple interactions | EXP | | 6480464 | Haloperidol results in decreased activity of and results in decreased expression of SOD2 protein | CTD | PMID:12482469 |
| hemin | multiple interactions | EXP | | 6480464 | Hemin promotes the reaction [Acetaminophen results in increased expression of SOD2 protein] | CTD | PMID:12051994 |
| hesperetin | increases expression | ISO | RGD:11330 | 6480464 | hesperetin results in increased expression of SOD2 protein | CTD | PMID:19023542 |
| hexachlorobenzene | affects expression | EXP | | 6480464 | Hexachlorobenzene affects the expression of SOD2 mRNA | CTD | PMID:15159207 |
| hydrogen peroxide | multiple interactions | ISO | RGD:730872 | 6480464 | 1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein]; more ... | CTD | PMID:20674559 |
| hydrogen peroxide | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Hydrogen Peroxide | CTD | PMID:11297530 PMID:18930813 |
| hydrogen peroxide | increases abundance | EXP | | 6480464 | SOD2 protein results in increased abundance of Hydrogen Peroxide | CTD | PMID:16162655 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [SOD2 protein results in increased abundance of Hydrogen Peroxide] which results in decreased activity of ACO2 protein | CTD | PMID:16162655 |
| hydrogen peroxide | multiple interactions | ISO | RGD:11330 | 6480464 | HSPB1 protein promotes the reaction [Hydrogen Peroxide results in increased activity of SOD2 protein]; more ... | CTD | PMID:14975446 |
| hydrogen peroxide | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Hydrogen Peroxide | CTD | PMID:18930813 PMID:11297530 |
| hydrogen peroxide | increases activity | ISO | RGD:11330 | 6480464 | Hydrogen Peroxide results in increased activity of SOD2 protein | CTD | PMID:14975446 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Blood Glucose results in increased chemical synthesis of Hydrogen Peroxide] which results in decreased activity of SOD2 protein | CTD | PMID:20620209 |
| hydrogen peroxide | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Hydrogen Peroxide | CTD | PMID:18930813 |
| hydrogen peroxide | increases chemical synthesis | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased chemical synthesis of Hydrogen Peroxide | CTD | PMID:22580338 |
| hydrogen peroxide | decreases secretion | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased secretion of Hydrogen Peroxide | CTD | PMID:22429591 |
| hydrogen peroxide | affects abundance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the abundance of Hydrogen Peroxide | CTD | PMID:22580338 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of SOD2 mRNA | CTD | PMID:11325355 |
| hydrogen peroxide | multiple interactions | ISO | RGD:11330 | 6480464 | Hydrogen Peroxide affects the reaction [SHC1 protein affects the expression of SOD2 mRNA] | CTD | PMID:16972253 |
| hydrogen peroxide | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Hydrogen Peroxide | CTD | PMID:9569045 |
| hydrogen peroxide | increases expression | ISO | RGD:730872 | 6480464 | Hydrogen Peroxide results in increased expression of SOD2 mRNA | CTD | PMID:8760145 |
| hydrogen peroxide | affects expression | ISO | RGD:730872 | 6480464 | Hydrogen Peroxide affects the expression of SOD2 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 mRNA] | CTD | PMID:8760145 |
| hydroquinone | decreases activity | ISO | RGD:730872 | 6480464 | hydroquinone results in decreased activity of SOD2 protein | CTD | PMID:15816534 |
| hydroquinone | decreases expression | ISO | RGD:730872 | 6480464 | hydroquinone results in decreased expression of SOD2 mRNA | CTD | PMID:15816534 |
| ibuprofen | increases expression | ISO | RGD:730872 | 6480464 | Ibuprofen results in increased expression of SOD2 mRNA | CTD | PMID:17070997 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Arachidonic Acid results in increased activity of SOD2 protein] | CTD | PMID:16982041 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Formaldehyde results in increased expression of SOD2 mRNA] | CTD | PMID:21983654 |
| indomethacin | multiple interactions | ISO | RGD:730872 | 6480464 | Indomethacin inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:12031898 |
| indomethacin | multiple interactions | ISO | RGD:11330 | 6480464 | Indomethacin affects the reaction [SOD2 protein affects the susceptibility to Acetylcholine] | CTD | PMID:20304815 |
| indomethacin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin results in decreased activity of SOD2 protein] | CTD | PMID:11523592 |
| indomethacin | decreases activity | EXP | | 6480464 | Indomethacin results in decreased activity of SOD2 protein | CTD | PMID:11523592 |
| ionomycin | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to [Tetradecanoylphorbol Acetate co-treated with Ionomycin] | CTD | PMID:22429591 |
| iron atom | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the reaction [Ethanol results in increased abundance of Iron]; more ... | CTD | PMID:19063909 |
| iron atom | affects abundance | ISO | RGD:730872 | 6480464 | SOD2 protein polymorphism affects the abundance of Iron | CTD | PMID:18760346 |
| iron atom | multiple interactions | ISO | RGD:730872 | 6480464 | Iron results in decreased expression of and results in decreased activity of SOD2 protein | CTD | PMID:18760346 |
| iron trichloride | multiple interactions | EXP | | 6480464 | [ferric chloride co-treated with Oxyquinoline] results in decreased expression of SOD2 protein; more ... | CTD | PMID:15019574 |
| isoeugenol | increases expression | ISO | RGD:730872 | 6480464 | isoeugenol results in increased expression of SOD2 mRNA | CTD | PMID:20566472 |
| isoflurane | multiple interactions | EXP | | 6480464 | Isoflurane results in decreased expression of and results in decreased activity of SOD2 protein; more ... | CTD | PMID:17693941 |
| isoniazide | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Isoniazid | CTD | PMID:19501153 |
| isotretinoin | decreases expression | ISO | RGD:730872 | 6480464 | Isotretinoin results in decreased expression of SOD2 mRNA | CTD | PMID:20436886 |
| kainic acid | decreases expression | EXP | | 6480464 | Kainic Acid results in decreased expression of SOD2 protein | CTD | PMID:10686417 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of SOD2 protein | CTD | PMID:10686417 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] | CTD | PMID:21554548 more ... |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] | CTD | PMID:20122981 more ... |
| L-ascorbic acid | increases expression | ISO | RGD:730872 | 6480464 | Ascorbic Acid deficiency results in increased expression of SOD2 mRNA; more ... | CTD | PMID:19932582 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] | CTD | PMID:21554548 more ... |
| L-ascorbic acid | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased susceptibility to Ascorbic Acid | CTD | PMID:15130278 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; more ... | CTD | PMID:18779489 |
| L-ascorbic acid | multiple interactions | ISO | RGD:730872 | 6480464 | Ascorbic Acid inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] | CTD | PMID:10942521 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of SOD2 mRNA] | CTD | PMID:15612528 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] | CTD | PMID:20876158 more ... |
| L-dehydroascorbic acid | multiple interactions | ISO | RGD:730872 | 6480464 | [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of SOD2 protein; more ... | CTD | PMID:20166893 |
| L-dehydroascorbic acid | increases expression | ISO | RGD:730872 | 6480464 | Dehydroascorbic Acid results in increased expression of SOD2 protein | CTD | PMID:20166893 |
| L-methionine | multiple interactions | ISO | RGD:730872 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of SOD2 protein] | CTD | PMID:22138271 |
| lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in decreased activity of SOD2 protein] | CTD | PMID:19951573 |
| lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [sodium arsenite results in decreased activity of SOD2 protein] | CTD | PMID:15804455 |
| losartan | decreases activity | EXP | | 6480464 | Losartan results in decreased activity of SOD2 protein | CTD | PMID:18765277 |
| lutein | multiple interactions | ISO | RGD:11330 | 6480464 | Lutein inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD2 mRNA] | CTD | PMID:22040935 |
| LY294002 | multiple interactions | ISO | RGD:730872 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [VEGFA protein results in increased expression of SOD2 mRNA] | CTD | PMID:15308628 |
| LY294002 | multiple interactions | ISO | RGD:11330 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased expression of SOD2 protein] | CTD | PMID:20542495 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of SOD2 mRNA | CTD | PMID:20596034 |
| LY294002 | multiple interactions | ISO | RGD:11330 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of SOD2 mRNA] | CTD | PMID:16256798 |
| malathion | multiple interactions | EXP | | 6480464 | alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein]; more ... | CTD | PMID:20194575 |
| manganese atom | increases expression | ISO | RGD:730872 | 6480464 | Manganese results in increased expression of SOD2 mRNA; more ... | CTD | PMID:17175027 |
| manganese atom | increases activity | ISO | RGD:730872 | 6480464 | Manganese results in increased activity of SOD2 protein | CTD | PMID:19093460 |
| manganese atom | increases activity | ISO | RGD:11330 | 6480464 | Manganese results in increased activity of SOD2 protein | CTD | PMID:18317567 |
| manganese atom | multiple interactions | EXP | | 6480464 | Manganese inhibits the reaction [Cadmium Chloride results in decreased activity of SOD2 protein] | CTD | PMID:12204541 |
| manganese atom | multiple interactions | ISO | RGD:11330 | 6480464 | Paroxetine inhibits the reaction [Manganese deficiency results in increased expression of SOD2 protein] | CTD | PMID:21312047 |
| manganese atom | increases expression | ISO | RGD:11330 | 6480464 | Manganese deficiency results in increased expression of SOD2 protein | CTD | PMID:21312047 |
| manganese(0) | increases expression | ISO | RGD:730872 | 6480464 | Manganese results in increased expression of SOD2 mRNA; more ... | CTD | PMID:17175027 |
| manganese(0) | increases activity | ISO | RGD:730872 | 6480464 | Manganese results in increased activity of SOD2 protein | CTD | PMID:19093460 |
| manganese(0) | increases activity | ISO | RGD:11330 | 6480464 | Manganese results in increased activity of SOD2 protein | CTD | PMID:18317567 |
| manganese(0) | multiple interactions | EXP | | 6480464 | Manganese inhibits the reaction [Cadmium Chloride results in decreased activity of SOD2 protein] | CTD | PMID:12204541 |
| manganese(0) | multiple interactions | ISO | RGD:11330 | 6480464 | Paroxetine inhibits the reaction [Manganese deficiency results in increased expression of SOD2 protein] | CTD | PMID:21312047 |
| manganese(0) | increases expression | ISO | RGD:11330 | 6480464 | Manganese deficiency results in increased expression of SOD2 protein | CTD | PMID:21312047 |
| manganese(II) chloride | increases expression | ISO | RGD:730872 | 6480464 | manganese chloride results in increased expression of SOD2 mRNA; more ... | CTD | PMID:17175027 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of SOD2 protein | CTD | PMID:22154916 |
| manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of SOD2 protein | CTD | PMID:15922012 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:730872 | 6480464 | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 protein; more ... | CTD | PMID:16709600 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:730872 | 6480464 | Medroxyprogesterone Acetate results in increased expression of SOD2 mRNA | CTD | PMID:11756571 PMID:20685861 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:730872 | 6480464 | Medroxyprogesterone Acetate results in increased expression of SOD2 mRNA | CTD | PMID:20685861 PMID:11756571 |
| medroxyprogesterone acetate | increases activity | ISO | RGD:730872 | 6480464 | Medroxyprogesterone Acetate results in increased activity of SOD2 protein | CTD | PMID:11756571 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:730872 | 6480464 | [Estradiol co-treated with Medroxyprogesterone Acetate] results in increased activity of SOD2 protein; more ... | CTD | PMID:12093828 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:730872 | 6480464 | Medroxyprogesterone Acetate results in increased expression of SOD2 mRNA | CTD | PMID:20685861 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:730872 | 6480464 | Medroxyprogesterone Acetate promotes the reaction [CREBBP protein binds to SOD2 promoter]; more ... | CTD | PMID:20685861 |
| melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of SOD2 mRNA | CTD | PMID:16098089 |
| melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of SOD2 mRNA | CTD | PMID:15589378 more ... |
| melatonin | multiple interactions | ISO | RGD:730872 | 6480464 | Melatonin inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] | CTD | PMID:10942521 |
| melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of SOD2 mRNA | CTD | PMID:16098089 PMID:21442002 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [isolevin results in increased expression of SOD2 protein] | CTD | PMID:20210856 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin results in decreased activity of SOD2 protein] | CTD | PMID:11523592 |
| menadione | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Vitamin K 3 | CTD | PMID:14660625 |
| menadione | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased susceptibility to Vitamin K 3 | CTD | PMID:15986238 |
| menadione | multiple interactions | ISO | RGD:730872 | 6480464 | [CAT protein co-treated with SOD2 protein] results in decreased susceptibility to Vitamin K 3 | CTD | PMID:12633745 |
| menadione | increases activity | EXP | | 6480464 | Vitamin K 3 results in increased activity of SOD2 protein | CTD | PMID:19265712 |
| menadione | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased activity of SOD2 protein] | CTD | PMID:19265712 |
| mercaptopurine | increases expression | ISO | RGD:730872 | 6480464 | 6-Mercaptopurine results in increased expression of SOD2 mRNA | CTD | PMID:18222062 |
| mercury dichloride | increases activity | EXP | | 6480464 | Mercuric Chloride results in increased activity of SOD2 protein | CTD | PMID:15977196 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of SOD2 mRNA | CTD | PMID:21232032 |
| mercury dichloride | multiple interactions | ISO | RGD:11330 | 6480464 | Mercuric Chloride results in decreased activity of and results in increased reduction of SOD2 protein | CTD | PMID:12111001 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of SOD2 protein | CTD | PMID:15977196 |
| metformin | increases expression | ISO | RGD:730872 | 6480464 | Metformin results in increased expression of SOD2 mRNA | CTD | PMID:16380484 |
| metformin | multiple interactions | ISO | RGD:730872 | 6480464 | PRKAA1 protein affects the reaction [Metformin results in increased expression of SOD2 mRNA] | CTD | PMID:16380484 |
| methamphetamine | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene polymorphism results in increased susceptibility to Methamphetamine | CTD | PMID:16807759 |
| methimazole | increases activity | EXP | | 6480464 | Methimazole results in increased activity of SOD2 protein | CTD | PMID:11521740 |
| microcystin-LR | decreases expression | ISO | RGD:11330 | 6480464 | cyanoginosin LR results in decreased expression of SOD2 mRNA | CTD | PMID:17654400 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Progesterone results in decreased expression of SOD2 mRNA] | CTD | PMID:16195479 |
| mitomycin C | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| morphine | increases expression | ISO | RGD:730872 | 6480464 | Morphine results in increased expression of SOD2 protein | CTD | PMID:20564181 |
| morphine | multiple interactions | ISO | RGD:11330 | 6480464 | Saquinavir inhibits the reaction [Morphine results in increased expression of SOD2 protein] | CTD | PMID:14871405 |
| morphine | increases expression | ISO | RGD:11330 | 6480464 | Morphine results in increased expression of SOD2 protein | CTD | PMID:14871405 |
| myxothiazol | multiple interactions | ISO | RGD:730872 | 6480464 | myxothiazol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] | CTD | PMID:11264281 |
| N-acetyl-beta-D-glucosamine | decreases expression | ISO | RGD:730872 | 6480464 | Acetylglucosamine results in decreased expression of SOD2 mRNA | CTD | PMID:18047607 |
| N-acetyl-D-glucosamine | decreases expression | ISO | RGD:730872 | 6480464 | Acetylglucosamine results in decreased expression of SOD2 mRNA | CTD | PMID:18047607 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:12031898 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in decreased expression of SOD2 protein] | CTD | PMID:22714038 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA] | CTD | PMID:16101137 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:18594523 |
| N-acetyl-L-cysteine | increases expression | ISO | RGD:11330 | 6480464 | Acetylcysteine results in increased expression of SOD2 mRNA; more ... | CTD | PMID:17010595 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of SOD2 mRNA | CTD | PMID:22429591 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:11330 | 6480464 | Acetylcysteine promotes the reaction [Oxygen results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:17010595 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [SOD2 protein affects the activity of AR protein]; more ... | CTD | PMID:18829485 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of SOD2 protein] | CTD | PMID:15904944 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:8760145 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein] | CTD | PMID:20674559 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein] | CTD | PMID:17309078 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of SOD2] | CTD | PMID:11264281 |
| N-methyl-N-nitrosurea | affects metabolic processing | ISO | RGD:11330 | 6480464 | Methylnitrosourea affects the metabolism of SOD2 protein | CTD | PMID:16052507 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:11330 | 6480464 | PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] | CTD | PMID:16052507 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein; more ... | CTD | PMID:17761372 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SOD2 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA | CTD | PMID:18544905 |
| naringin | multiple interactions | ISO | RGD:11330 | 6480464 | naringin inhibits the reaction [Ferric Compounds results in decreased activity of SOD2 protein] | CTD | PMID:21345335 |
| nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of SOD2 mRNA | CTD | PMID:19440498 |
| nickel dichloride | increases expression | ISO | RGD:730872 | 6480464 | nickel chloride results in increased expression of SOD2 mRNA | CTD | PMID:17312168 |
| nickel sulfate | increases expression | ISO | RGD:730872 | 6480464 | nickel sulfate results in increased expression of SOD2 mRNA | CTD | PMID:16314067 more ... |
| nickel sulfate | increases expression | ISO | RGD:730872 | 6480464 | nickel sulfate results in increased expression of SOD2 mRNA | CTD | PMID:20566472 more ... |
| nickel sulfate | increases expression | ISO | RGD:730872 | 6480464 | nickel sulfate results in increased expression of SOD2 mRNA | CTD | PMID:16314067 more ... |
| nifedipine | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Nifedipine | CTD | PMID:19501153 |
| nifedipine | increases expression | ISO | RGD:730872 | 6480464 | Nifedipine results in increased expression of SOD2 protein; more ... | CTD | PMID:18327084 |
| nifedipine | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to Nifedipine | CTD | PMID:18327084 |
| nimesulide | decreases expression | ISO | RGD:730872 | 6480464 | nimesulide results in decreased expression of SOD2 protein | CTD | PMID:18848576 PMID:16969492 |
| nimesulide | decreases expression | ISO | RGD:730872 | 6480464 | nimesulide results in decreased expression of SOD2 protein | CTD | PMID:16969492 PMID:18848576 |
| nitric oxide | increases expression | EXP | | 6480464 | Nitric Oxide deficiency results in increased expression of SOD2 protein | CTD | PMID:15925750 |
| nitric oxide | multiple interactions | EXP | | 6480464 | Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of SOD2 mRNA] | CTD | PMID:21983654 |
| nitric oxide | multiple interactions | EXP | | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:14996425 |
| nitric oxide | multiple interactions | ISO | RGD:730872 | 6480464 | [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 protein; more ... | CTD | PMID:19320461 |
| nitric oxide | affects abundance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the abundance of Nitric Oxide | CTD | PMID:20110409 |
| nitric oxide | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [Nitric Oxide deficiency results in increased expression of SOD2 protein] | CTD | PMID:15925750 |
| nitroglycerin | multiple interactions | EXP | | 6480464 | Nitroglycerin results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:12860443 PMID:14732477 |
| nitroprusside | multiple interactions | ISO | RGD:730872 | 6480464 | 1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein]; more ... | CTD | PMID:20674559 |
| ochratoxin A | increases expression | ISO | RGD:730872 | 6480464 | ochratoxin A results in increased expression of SOD2 mRNA | CTD | PMID:17316727 |
| okadaic acid | multiple interactions | ISO | RGD:730872 | 6480464 | [Okadaic Acid co-treated with gambierol] results in increased expression of SOD2 protein | CTD | PMID:19397276 |
| ozone | multiple interactions | ISO | RGD:11330 | 6480464 | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of SOD2 mRNA] | CTD | PMID:20417186 |
| ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of SOD2 mRNA | CTD | PMID:16716893 |
| ozone | increases expression | ISO | RGD:11330 | 6480464 | Ozone results in increased expression of SOD2 mRNA | CTD | PMID:20417186 |
| paclitaxel | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paclitaxel | CTD | PMID:18594523 |
| paclitaxel | multiple interactions | ISO | RGD:730872 | 6480464 | Acetylcysteine affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel]; more ... | CTD | PMID:18594523 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SOD2 protein | CTD | PMID:12051994 |
| paracetamol | multiple interactions | ISO | RGD:11330 | 6480464 | S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD2 protein] | CTD | PMID:22683606 |
| paracetamol | decreases activity | ISO | RGD:11330 | 6480464 | Acetaminophen results in decreased activity of SOD2 protein | CTD | PMID:22683606 |
| paracetamol | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased susceptibility to Acetaminophen | CTD | PMID:21241727 |
| paracetamol | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 gene mutant form promotes the reaction [Acetaminophen affects the transport of AIFM1 protein] | CTD | PMID:21241727 |
| paracetamol | decreases expression | ISO | RGD:730872 | 6480464 | Acetaminophen results in decreased expression of SOD2 mRNA | CTD | PMID:21420995 |
| paracetamol | multiple interactions | EXP | | 6480464 | SOD2 protein affects the reaction [Acetaminophen affects the expression of HMOX1 protein] | CTD | PMID:19647030 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SOD2 protein | CTD | PMID:16538043 |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased activity of SOD2 protein] | CTD | PMID:19265712 |
| paracetamol | affects response to substance | EXP | | 6480464 | SOD2 protein affects the susceptibility to Acetaminophen | CTD | PMID:19647030 |
| paracetamol | affects response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to Acetaminophen | CTD | PMID:19332662 |
| paracetamol | affects expression | ISO | RGD:11330 | 6480464 | Acetaminophen affects the expression of SOD2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:11330 | 6480464 | Acetaminophen results in increased expression of SOD2 protein | CTD | PMID:21329376 |
| paracetamol | multiple interactions | EXP | | 6480464 | Hemin promotes the reaction [Acetaminophen results in increased expression of SOD2 protein] | CTD | PMID:12051994 |
| paraquat | increases activity | ISO | RGD:730872 | 6480464 | Paraquat results in increased activity of SOD2 protein | CTD | PMID:10644010 |
| paraquat | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:10969820 more ... |
| paraquat | multiple interactions | ISO | RGD:730872 | 6480464 | [Paraquat co-treated with SOD2 protein] results in increased cleavage of LMNB1 protein | CTD | PMID:19100713 |
| paraquat | decreases expression | ISO | RGD:11330 | 6480464 | Paraquat results in decreased expression of SOD2 protein | CTD | PMID:21765237 |
| paraquat | increases expression | ISO | RGD:11330 | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:21688324 |
| paraquat | multiple interactions | ISO | RGD:11330 | 6480464 | Dapsone inhibits the reaction [Paraquat results in decreased expression of SOD2 protein] | CTD | PMID:21765237 |
| paraquat | multiple interactions | ISO | RGD:11330 | 6480464 | APOD protein affects the reaction [Paraquat results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:21688324 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:10959798 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:17935786 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:10959798 more ... |
| paraquat | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:10969820 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:10959798 more ... |
| paraquat | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:14660625 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:15754033 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:17935786 more ... |
| paraquat | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 gene mutant form results in increased susceptibility to Paraquat | CTD | PMID:15182862 PMID:16288465 |
| paraquat | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:14660625 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:15754033 more ... |
| paraquat | increases activity | EXP | | 6480464 | Paraquat results in increased activity of SOD2 protein | CTD | PMID:17015168 |
| paraquat | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD2 protein]; more ... | CTD | PMID:17015168 |
| paraquat | multiple interactions | ISO | RGD:11330 | 6480464 | [TRP53 protein results in decreased expression of SOD2 mRNA] which results in increased susceptibility to Paraquat | CTD | PMID:10969820 |
| paraquat | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:10969820 |
| paraquat | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 gene mutant form results in increased susceptibility to Paraquat | CTD | PMID:16288465 PMID:15182862 |
| paraquat | decreases expression | ISO | RGD:11330 | 6480464 | Paraquat results in decreased expression of SOD2 mRNA | CTD | PMID:17215068 |
| paraquat | multiple interactions | ISO | RGD:11330 | 6480464 | Oxygen affects the reaction [SOD2 gene mutant form affects the susceptibility to Paraquat] | CTD | PMID:11156968 |
| paraquat | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Paraquat | CTD | PMID:11306437 more ... |
| paraquat | multiple interactions | ISO | RGD:11330 | 6480464 | EPO protein inhibits the reaction [SOD2 gene mutant form results in increased susceptibility to Paraquat] | CTD | PMID:16288465 |
| paraquat | increases expression | ISO | RGD:730872 | 6480464 | Paraquat results in increased expression of SOD2 protein | CTD | PMID:10644010 |
| paraquat | multiple interactions | ISO | RGD:730872 | 6480464 | [Paraquat results in increased activity of SOD2 protein] which results in decreased expression of ICAM1 protein | CTD | PMID:10644010 |
| paraquat | increases expression | ISO | RGD:730872 | 6480464 | Paraquat results in increased expression of SOD2 mRNA | CTD | PMID:14503839 |
| paricalcitol | multiple interactions | ISO | RGD:11330 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of SOD2 protein | CTD | PMID:20720404 |
| paricalcitol | decreases expression | ISO | RGD:11330 | 6480464 | paricalcitol results in decreased expression of SOD2 protein | CTD | PMID:20720404 |
| paroxetine | multiple interactions | ISO | RGD:11330 | 6480464 | Paroxetine inhibits the reaction [Manganese deficiency results in increased expression of SOD2 protein] | CTD | PMID:21312047 |
| peroxynitrous acid | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to [alatrofloxacin results in increased abundance of Peroxynitrous Acid] | CTD | PMID:20655887 |
| peroxynitrous acid | multiple interactions | ISO | RGD:730872 | 6480464 | CAT protein promotes the reaction [SOD2 protein results in decreased susceptibility to Peroxynitrous Acid]; more ... | CTD | PMID:15855331 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of SOD2 mRNA | CTD | PMID:9806150 |
| phlorizin | decreases expression | ISO | RGD:11330 | 6480464 | Phlorhizin results in decreased expression of SOD2 mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of SOD2 protein; more ... | CTD | PMID:17309078 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein | CTD | PMID:15330761 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA | CTD | PMID:10669635 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [[SP1 protein binds to SOD2 promoter] which results in increased expression of SOD2 mRNA] | CTD | PMID:10669635 PMID:10669635 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | [Tetradecanoylphorbol Acetate results in increased expression of TNF] which results in increased expression of SOD2 | CTD | PMID:10769695 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of SOD2 protein | CTD | PMID:12161520 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein | CTD | PMID:21705328 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA | CTD | PMID:10669635 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal]; more ... | CTD | PMID:11507057 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:15330761 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of SOD2 protein]; more ... | CTD | PMID:12161520 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOD2 mRNA | CTD | PMID:18958680 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein | CTD | PMID:21705328 PMID:20831825 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA | CTD | PMID:21705328 PMID:17309078 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to [Tetradecanoylphorbol Acetate co-treated with Ionomycin] | CTD | PMID:22429591 |
| phorbol 13-acetate 12-myristate | increases abundance | ISO | RGD:730872 | 6480464 | [Tetradecanoylphorbol Acetate results in increased abundance of Reactive Oxygen Species] which results in increased abundance of SOD2 | CTD | PMID:21705328 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:21705328 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCR1 mRNA]; more ... | CTD | PMID:21045076 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730872 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA | CTD | PMID:17309078 |
| phosgene | affects expression | ISO | RGD:11330 | 6480464 | Phosgene affects the expression of SOD2 mRNA | CTD | PMID:16300373 |
| pirinixic acid | increases expression | ISO | RGD:11330 | 6480464 | pirinixic acid results in increased expression of SOD2 mRNA | CTD | PMID:15375163 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SOD2 mRNA | CTD | PMID:16940010 |
| potassium atom | decreases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased abundance of Potassium | CTD | PMID:19917352 |
| potassium atom | decreases expression | ISO | RGD:11330 | 6480464 | Potassium deficiency results in decreased expression of SOD2 mRNA | CTD | PMID:12548706 |
| potassium iodide | multiple interactions | ISO | RGD:730872 | 6480464 | Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased expression of SOD2 protein] | CTD | PMID:18588940 |
| progesterone | multiple interactions | ISO | RGD:11330 | 6480464 | Estradiol inhibits the reaction [Progesterone results in decreased expression of SOD2 mRNA] | CTD | PMID:16195479 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of SOD2 mRNA | CTD | PMID:16195479 |
| progesterone | decreases activity | EXP | | 6480464 | Progesterone results in decreased activity of SOD2 protein | CTD | PMID:16195479 |
| progesterone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Progesterone results in decreased expression of SOD2 mRNA]; more ... | CTD | PMID:16195479 |
| progesterone | decreases expression | ISO | RGD:11330 | 6480464 | Progesterone results in decreased expression of SOD2 mRNA | CTD | PMID:16195479 |
| propofol | increases expression | EXP | | 6480464 | Propofol results in increased expression of SOD2 protein | CTD | PMID:21468576 |
| propofol | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] | CTD | PMID:22015447 |
| prostaglandin E2 | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Glucose results in increased chemical synthesis of Dinoprostone] | CTD | PMID:14514642 |
| pterostilbene | multiple interactions | ISO | RGD:730872 | 6480464 | SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] | CTD | PMID:18852136 |
| pterostilbene | increases activity | ISO | RGD:730872 | 6480464 | pterostilbene results in increased activity of SOD2 protein | CTD | PMID:22572619 PMID:22450950 |
| pterostilbene | increases activity | ISO | RGD:730872 | 6480464 | pterostilbene results in increased activity of SOD2 protein | CTD | PMID:22450950 PMID:22572619 |
| pterostilbene | increases expression | ISO | RGD:730872 | 6480464 | pterostilbene results in increased expression of SOD2 mRNA | CTD | PMID:22450950 |
| purine-6-thiol | increases expression | ISO | RGD:730872 | 6480464 | 6-Mercaptopurine results in increased expression of SOD2 mRNA | CTD | PMID:18222062 |
| quartz | increases expression | EXP | | 6480464 | Quartz results in increased expression of SOD2 mRNA | CTD | PMID:19836432 |
| quercetin | multiple interactions | ISO | RGD:730872 | 6480464 | [pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein; more ... | CTD | PMID:18852136 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of SOD2 mRNA | CTD | PMID:12756520 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | CTD | PMID:16366677 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17070561 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin analog inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17079513 |
| quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of SOD2 mRNA; more ... | CTD | PMID:11543823 |
| quinolin-8-ol | multiple interactions | EXP | | 6480464 | [ferric chloride co-treated with Oxyquinoline] results in increased expression of SOD2 protein; more ... | CTD | PMID:15019574 |
| raloxifene | multiple interactions | ISO | RGD:730872 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of SOD2 mRNA | CTD | PMID:19059307 |
| rel-(3R,5S)-fluvastatin | multiple interactions | ISO | RGD:11330 | 6480464 | [fluvastatin co-treated with Doxorubicin] results in increased expression of SOD2 protein | CTD | PMID:19147586 |
| resveratrol | increases expression | ISO | RGD:730872 | 6480464 | resveratrol results in increased expression of SOD2 mRNA | CTD | PMID:17261084 |
| resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 PMID:23090186 |
| resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 | CTD | PMID:19656070 |
| resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 mRNA | CTD | PMID:20610621 PMID:22878646 |
| resveratrol | increases activity | ISO | RGD:11330 | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:21270273 PMID:21454355 |
| resveratrol | decreases expression | ISO | RGD:730872 | 6480464 | resveratrol results in decreased expression of SOD2 mRNA | CTD | PMID:21371465 |
| resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:23090186 |
| resveratrol | increases expression | ISO | RGD:730872 | 6480464 | resveratrol results in increased expression of SOD2 | CTD | PMID:20610621 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SOD2 protein | CTD | PMID:21666113 |
| resveratrol | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in increased susceptibility to resveratrol | CTD | PMID:20542495 |
| resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 |
| resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Nicotine results in decreased expression of SOD2 protein] | CTD | PMID:22687363 |
| resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | [resveratrol co-treated with Excitatory Amino Acid Agents] results in increased expression of SOD2 protein; more ... | CTD | PMID:20542495 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:20861279 |
| resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 more ... |
| resveratrol | multiple interactions | ISO | RGD:730872 | 6480464 | resveratrol inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] | CTD | PMID:10942521 |
| resveratrol | increases activity | ISO | RGD:11330 | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:21270273 |
| resveratrol | decreases metabolic processing | ISO | RGD:11330 | 6480464 | resveratrol results in decreased metabolism of SOD2 protein | CTD | PMID:21270273 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of SOD2 protein alternative form | CTD | PMID:17401679 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:19303434 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of SOD2 mRNA | CTD | PMID:15748624 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | CTD | PMID:16366677 |
| resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of SOD2 mRNA] | CTD | PMID:17374693 |
| rosiglitazone | increases activity | ISO | RGD:730872 | 6480464 | rosiglitazone results in increased activity of SOD2 protein | CTD | PMID:17255338 |
| rosiglitazone | affects expression | ISO | RGD:730872 | 6480464 | rosiglitazone affects the expression of SOD2 protein | CTD | PMID:19556978 |
| rosiglitazone | increases expression | ISO | RGD:11330 | 6480464 | rosiglitazone results in increased expression of SOD2 mRNA; more ... | CTD | PMID:19226370 |
| rosiglitazone | multiple interactions | ISO | RGD:11330 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:19226370 |
| rosiglitazone | multiple interactions | ISO | RGD:11330 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SOD2 mRNA | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:730872 | 6480464 | rosiglitazone results in increased expression of SOD2 mRNA | CTD | PMID:17255338 |
| rotenone | multiple interactions | ISO | RGD:730872 | 6480464 | Rotenone results in increased expression of and results in increased activity of SOD2 protein; more ... | CTD | PMID:15904944 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SOD2 mRNA | CTD | PMID:19818760 PMID:21807080 |
| rotenone | multiple interactions | EXP | | 6480464 | Antiparkinson Agents inhibits the reaction [Rotenone results in decreased expression of SOD2 mRNA] | CTD | PMID:21807080 |
| rotenone | multiple interactions | ISO | RGD:730872 | 6480464 | [Rotenone results in increased abundance of Superoxides] which results in increased expression of SOD2 protein | CTD | PMID:16179351 |
| rotenone | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17079513 PMID:17070561 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SOD2 mRNA | CTD | PMID:17079513 |
| rotenone | increases activity | EXP | | 6480464 | Rotenone results in increased activity of SOD2 protein | CTD | PMID:17079513 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SOD2 mRNA | CTD | PMID:19818760 |
| rotenone | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17070561 |
| rotenone | multiple interactions | EXP | | 6480464 | Quercetin analog inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17079513 |
| rotenone | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Rotenone results in increased activity of SOD2 protein]; more ... | CTD | PMID:17070561 PMID:17079513 |
| rotenone | decreases expression | ISO | RGD:11330 | 6480464 | Rotenone results in decreased expression of SOD2 mRNA | CTD | PMID:17657281 |
| rotenone | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased susceptibility to Rotenone | CTD | PMID:10463952 |
| rotenone | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Rotenone | CTD | PMID:18032788 |
| rotenone | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [Rotenone results in increased expression of BECN1 protein] | CTD | PMID:18032788 |
| S-adenosyl-L-methionine | multiple interactions | ISO | RGD:11330 | 6480464 | S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD2 protein] | CTD | PMID:22683606 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased susceptibility to Buthionine Sulfoximine | CTD | PMID:15130278 |
| salicyl alcohol | multiple interactions | EXP | | 6480464 | salicyl alcohol inhibits the reaction [2,2'-azobis(2-amidinopropane) results in decreased activity of SOD2 protein] | CTD | PMID:19665455 |
| saquinavir | multiple interactions | ISO | RGD:11330 | 6480464 | Saquinavir inhibits the reaction [Morphine results in increased expression of SOD2 protein] | CTD | PMID:14871405 |
| selenium atom | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene SNP affects the susceptibility to Selenium | CTD | PMID:19074884 |
| selenium atom | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 gene polymorphism affects the susceptibility to Selenium | CTD | PMID:19528373 |
| selenium atom | multiple interactions | ISO | RGD:730872 | 6480464 | SEPP1 gene SNP affects the reaction [SOD2 gene SNP affects the susceptibility to Selenium] | CTD | PMID:19074884 |
| selenium atom | increases expression | ISO | RGD:730872 | 6480464 | Selenium results in increased expression of SOD2 mRNA | CTD | PMID:17293063 |
| selenomethionine | increases expression | ISO | RGD:730872 | 6480464 | Selenomethionine results in increased expression of SOD2 protein | CTD | PMID:21215776 |
| silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of SOD2 mRNA | CTD | PMID:21602193 PMID:12788471 |
| silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of SOD2 mRNA | CTD | PMID:12788471 PMID:21602193 |
| silver atom | increases expression | ISO | RGD:11330 | 6480464 | Silver results in increased expression of SOD2 mRNA | CTD | PMID:19429238 |
| silver(0) | increases expression | ISO | RGD:11330 | 6480464 | Silver results in increased expression of SOD2 mRNA | CTD | PMID:19429238 |
| simvastatin | decreases expression | ISO | RGD:11330 | 6480464 | Simvastatin results in decreased expression of SOD2 mRNA | CTD | PMID:20883752 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of SOD2 mRNA | CTD | PMID:16414398 |
| sodium atom | increases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased abundance of Sodium | CTD | PMID:19917352 |
| sodium chloride | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; more ... | CTD | PMID:22431579 |
| sodium dichromate | multiple interactions | ISO | RGD:11330 | 6480464 | JUN protein affects the reaction [sodium bichromate results in decreased expression of SOD2 protein] | CTD | PMID:21047991 |
| sodium dichromate | increases expression | ISO | RGD:11330 | 6480464 | sodium bichromate results in increased expression of SOD2 mRNA | CTD | PMID:22155349 |
| sodium dichromate | decreases expression | ISO | RGD:11330 | 6480464 | sodium bichromate results in decreased expression of SOD2 protein | CTD | PMID:21047991 |
| stearic acid | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of SOD2 mRNA] | CTD | PMID:17374693 |
| stearic acid | decreases expression | ISO | RGD:11330 | 6480464 | stearic acid results in decreased expression of SOD2 mRNA | CTD | PMID:17374693 |
| streptozocin | increases expression | ISO | RGD:11330 | 6480464 | Streptozocin results in increased expression of SOD2 mRNA | CTD | PMID:15298345 |
| streptozocin | decreases activity | EXP | | 6480464 | Streptozocin results in decreased activity of SOD2 protein | CTD | PMID:19951573 PMID:20053369 |
| streptozocin | multiple interactions | EXP | | 6480464 | arjunolic acid inhibits the reaction [Streptozocin results in decreased activity of SOD2 protein] | CTD | PMID:20053369 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SOD2 protein | CTD | PMID:18779489 PMID:19634143 |
| streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Cholesterol, Dietary] results in decreased expression of SOD2 protein; more ... | CTD | PMID:14871415 |
| streptozocin | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; more ... | CTD | PMID:18779489 |
| streptozocin | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased susceptibility to Streptozocin | CTD | PMID:15855331 |
| streptozocin | multiple interactions | ISO | RGD:730872 | 6480464 | CAT protein promotes the reaction [SOD2 protein results in decreased susceptibility to Streptozocin]; more ... | CTD | PMID:15855331 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SOD2 mRNA | CTD | PMID:18779489 |
| streptozocin | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in decreased activity of SOD2 protein] | CTD | PMID:19951573 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SOD2 protein | CTD | PMID:19634143 |
| streptozocin | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein] | CTD | PMID:19634143 |
| streptozocin | decreases activity | EXP | | 6480464 | Streptozocin results in decreased activity of SOD2 protein | CTD | PMID:19951573 |
| sulfamethoxazole | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Sulfamethoxazole | CTD | PMID:19501153 |
| sulindac | multiple interactions | ISO | RGD:730872 | 6480464 | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA] | CTD | PMID:15190207 |
| superoxide | decreases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased abundance of Superoxides | CTD | PMID:19265433 |
| superoxide | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the reaction [troglitazone results in increased abundance of Superoxides] | CTD | PMID:17150972 |
| superoxide | increases expression | ISO | RGD:730872 | 6480464 | Superoxides results in increased expression of SOD2 protein | CTD | PMID:16179351 |
| superoxide | multiple interactions | ISO | RGD:730872 | 6480464 | SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein] | CTD | PMID:11050244 |
| superoxide | multiple interactions | ISO | RGD:730872 | 6480464 | [Rotenone results in increased abundance of Superoxides] which results in increased expression of SOD2 protein | CTD | PMID:16179351 |
| superoxide | multiple interactions | ISO | RGD:11330 | 6480464 | [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in decreased abundance of Superoxides] which results in decreased expression of SOD2 protein | CTD | PMID:19193722 |
| superoxide | decreases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased abundance of Superoxides | CTD | PMID:16179351 PMID:19265433 |
| superoxide | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [SOD2 protein affects the abundance of Superoxides] | CTD | PMID:17901229 |
| superoxide | affects abundance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the abundance of Superoxides | CTD | PMID:20304815 |
| superoxide | affects chemical synthesis | ISO | RGD:11330 | 6480464 | SOD2 protein affects the chemical synthesis of Superoxides | CTD | PMID:20638473 |
| superoxide | affects abundance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the abundance of Superoxides | CTD | PMID:18594523 |
| superoxide | increases metabolic processing | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased metabolism of Superoxides | CTD | PMID:19265433 |
| tacrolimus hydrate | increases response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein results in increased susceptibility to Tacrolimus | CTD | PMID:14675044 |
| tamoxifen | multiple interactions | ISO | RGD:730872 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of SOD2 mRNA | CTD | PMID:19059307 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of SOD2 protein | CTD | PMID:21966433 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased activity of SOD2 protein] | CTD | PMID:21966433 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of SOD2 | CTD | PMID:17901229 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [SOD2 protein affects the abundance of Superoxides] | CTD | PMID:17901229 |
| tamoxifen | affects expression | ISO | RGD:11330 | 6480464 | Tamoxifen affects the expression of SOD2 mRNA | CTD | PMID:17555576 |
| tamoxifen | increases expression | ISO | RGD:730872 | 6480464 | Tamoxifen results in increased expression of SOD2 mRNA | CTD | PMID:15604281 |
| temozolomide | multiple interactions | ISO | RGD:730872 | 6480464 | temozolomide inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] | CTD | PMID:17638900 |
| temozolomide | decreases expression | ISO | RGD:730872 | 6480464 | temozolomide results in decreased expression of SOD2 mRNA | CTD | PMID:17638900 |
| temozolomide | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:730872 | 6480464 | tert-Butylhydroperoxide results in increased expression of SOD2 mRNA | CTD | PMID:15336504 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:730872 | 6480464 | tert-Butylhydroperoxide results in increased expression of SOD2 mRNA | CTD | PMID:16636651 more ... |
| tert-butyl hydroperoxide | affects response to substance | ISO | RGD:730872 | 6480464 | SOD2 protein affects the susceptibility to tert-Butylhydroperoxide | CTD | PMID:20107204 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:730872 | 6480464 | tert-Butylhydroperoxide results in increased expression of SOD2 mRNA | CTD | PMID:16636651 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:11330 | 6480464 | tert-Butylhydroperoxide results in increased expression of SOD2 mRNA | CTD | PMID:16704919 |
| tert-butyl hydroperoxide | increases activity | ISO | RGD:11330 | 6480464 | tert-Butylhydroperoxide results in increased activity of SOD2 protein | CTD | PMID:16704919 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:730872 | 6480464 | tert-Butylhydroperoxide results in increased expression of SOD2 mRNA | CTD | PMID:17003459 more ... |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:730872 | 6480464 | MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA] | CTD | PMID:16636651 |
| tert-butyl hydroperoxide | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide | CTD | PMID:15182862 |
| testosterone | multiple interactions | EXP | | 6480464 | Dihydrotestosterone inhibits the reaction [Testosterone deficiency results in increased expression of SOD2 mRNA]; more ... | CTD | PMID:20850791 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone deficiency results in increased expression of SOD2 mRNA; more ... | CTD | PMID:20850791 |
| tetrachloromethane | affects expression | ISO | RGD:11330 | 6480464 | Carbon Tetrachloride affects the expression of SOD2 mRNA | CTD | PMID:17484886 |
| tetrathiomolybdate(2-) | increases expression | ISO | RGD:730872 | 6480464 | tetrathiomolybdate analog results in increased expression of SOD2 mRNA; more ... | CTD | PMID:19323979 |
| thioacetamide | increases activity | EXP | | 6480464 | Thioacetamide results in increased activity of SOD2 protein | CTD | PMID:12009419 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SOD2 mRNA | CTD | PMID:12009419 |
| titanium dioxide | increases expression | ISO | RGD:730872 | 6480464 | titanium dioxide results in increased expression of SOD2 mRNA | CTD | PMID:19695317 |
| titanium dioxide | decreases response to substance | ISO | RGD:730872 | 6480464 | SOD2 results in decreased susceptibility to titanium dioxide | CTD | PMID:22973466 |
| trans-resveratrol | increases expression | ISO | RGD:730872 | 6480464 | resveratrol results in increased expression of SOD2 mRNA | CTD | PMID:17261084 |
| trans-resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 PMID:23090186 |
| trans-resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 | CTD | PMID:19656070 |
| trans-resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 mRNA | CTD | PMID:20610621 PMID:22878646 |
| trans-resveratrol | increases activity | ISO | RGD:11330 | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:21270273 PMID:21454355 |
| trans-resveratrol | decreases expression | ISO | RGD:730872 | 6480464 | resveratrol results in decreased expression of SOD2 mRNA | CTD | PMID:21371465 |
| trans-resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of SOD2 protein] | CTD | PMID:23090186 |
| trans-resveratrol | increases expression | ISO | RGD:730872 | 6480464 | resveratrol results in increased expression of SOD2 | CTD | PMID:20610621 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SOD2 protein | CTD | PMID:21666113 |
| trans-resveratrol | increases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in increased susceptibility to resveratrol | CTD | PMID:20542495 |
| trans-resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 |
| trans-resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [Nicotine results in decreased expression of SOD2 protein] | CTD | PMID:22687363 |
| trans-resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | [resveratrol co-treated with Excitatory Amino Acid Agents] results in increased expression of SOD2 protein; more ... | CTD | PMID:20542495 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:20861279 |
| trans-resveratrol | increases expression | ISO | RGD:11330 | 6480464 | resveratrol results in increased expression of SOD2 protein | CTD | PMID:20542495 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:730872 | 6480464 | resveratrol inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mRNA] | CTD | PMID:10942521 |
| trans-resveratrol | increases activity | ISO | RGD:11330 | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:21270273 |
| trans-resveratrol | decreases metabolic processing | ISO | RGD:11330 | 6480464 | resveratrol results in decreased metabolism of SOD2 protein | CTD | PMID:21270273 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of SOD2 protein alternative form | CTD | PMID:17401679 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of SOD2 protein | CTD | PMID:19303434 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of SOD2 mRNA | CTD | PMID:15748624 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | CTD | PMID:16366677 |
| trans-resveratrol | multiple interactions | ISO | RGD:11330 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of SOD2 mRNA] | CTD | PMID:17374693 |
| trazodone | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Trazodone | CTD | PMID:19501153 |
| trichostatin A | multiple interactions | ISO | RGD:730872 | 6480464 | [trichostatin A co-treated with decitabine] results in increased expression of SOD2 protein | CTD | PMID:19294695 |
| troglitazone | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to troglitazone | CTD | PMID:19501153 |
| troglitazone | affects response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to troglitazone | CTD | PMID:17150972 PMID:18495193 |
| troglitazone | multiple interactions | ISO | RGD:11330 | 6480464 | SOD2 protein affects the reaction [troglitazone results in increased abundance of Superoxides] | CTD | PMID:17150972 |
| troglitazone | increases expression | ISO | RGD:11330 | 6480464 | troglitazone results in increased expression of SOD2 protein | CTD | PMID:18495193 |
| troglitazone | decreases expression | ISO | RGD:11330 | 6480464 | troglitazone results in decreased expression of SOD2 mRNA | CTD | PMID:12732648 |
| troglitazone | affects response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein affects the susceptibility to troglitazone | CTD | PMID:18495193 |
| troglitazone | increases expression | ISO | RGD:730872 | 6480464 | troglitazone results in increased expression of SOD2 mRNA | CTD | PMID:19140230 |
| troglitazone | decreases expression | ISO | RGD:730872 | 6480464 | troglitazone results in decreased expression of SOD2 | CTD | PMID:20860658 |
| urea | decreases abundance | ISO | RGD:730872 | 6480464 | SOD2 protein results in decreased abundance of Urea | CTD | PMID:19917352 |
| uric acid | multiple interactions | ISO | RGD:11330 | 6480464 | Uric Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of SOD2 protein] | CTD | PMID:21767162 |
| valproic acid | decreases expression | ISO | RGD:11330 | 6480464 | Valproic Acid results in decreased expression of SOD2 mRNA | CTD | PMID:22045034 |
| vancomycin | increases expression | ISO | RGD:11330 | 6480464 | Vancomycin results in increased expression of SOD2 mRNA | CTD | PMID:18930951 |
| verapamil | multiple interactions | EXP | | 6480464 | Verapamil inhibits the reaction [Dexamethasone inhibits the reaction [Paraquat results in increased activity of SOD2 protein]] | CTD | PMID:17015168 |
| wortmannin | increases expression | EXP | | 6480464 | wortmannin results in increased expression of SOD2 mRNA | CTD | PMID:20596034 |
| WR-1065 | increases expression | ISO | RGD:730872 | 6480464 | WR 1065 results in increased expression of SOD2 mRNA | CTD | PMID:11390188 more ... |
| WR-1065 | multiple interactions | ISO | RGD:730872 | 6480464 | helenalin inhibits the reaction [WR 1065 results in increased expression of SOD2 protein] | CTD | PMID:16540396 |
| WR-1065 | increases activity | ISO | RGD:11330 | 6480464 | WR 1065 results in increased activity of SOD2 | CTD | PMID:21945096 |
| WR-1065 | increases expression | ISO | RGD:730872 | 6480464 | WR 1065 results in increased expression of SOD2 protein | CTD | PMID:16540396 |
| WR-1065 | multiple interactions | ISO | RGD:11330 | 6480464 | TNFRSF1A protein affects the reaction [WR 1065 results in increased activity of SOD2]; more ... | CTD | PMID:21945096 |
| WR-1065 | multiple interactions | ISO | RGD:730872 | 6480464 | WR 1065 results in increased expression of and results in increased activity of SOD2 protein | CTD | PMID:17388698 |
| zebularine | multiple interactions | ISO | RGD:730872 | 6480464 | [pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 gene] which results in increased expression of SOD2 protein | CTD | PMID:17895890 PMID:17895890 |
| zebularine | decreases methylation | ISO | RGD:730872 | 6480464 | pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 promoter | CTD | PMID:15908783 PMID:17895890 |
| zebularine | multiple interactions | ISO | RGD:730872 | 6480464 | [pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 promoter] which results in increased expression of SOD2 protein; more ... | CTD | PMID:15908783 PMID:15908783 |
| zebularine | decreases methylation | ISO | RGD:730872 | 6480464 | pyrimidin-2-one beta-ribofuranoside results in decreased methylation of SOD2 promoter | CTD | PMID:17895890 |
| zerumbone | increases expression | ISO | RGD:11330 | 6480464 | zerumbone results in increased expression of SOD2 mRNA | CTD | PMID:15122579 |
| zidovudine | decreases response to substance | ISO | RGD:11330 | 6480464 | SOD2 protein results in decreased susceptibility to Zidovudine | CTD | PMID:19398959 |
| zidovudine | multiple interactions | EXP | | 6480464 | [SOD2 co-treated with CYP3A4] affects the susceptibility to Zidovudine | CTD | PMID:19501153 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SOD2 mRNA | CTD | PMID:20128680 |
| zinc atom | decreases activity | EXP | | 6480464 | Zinc results in decreased activity of SOD2 protein | CTD | PMID:22127830 |
| zinc protoporphyrin | multiple interactions | ISO | RGD:730872 | 6480464 | zinc protoporphyrin inhibits the reaction [HIF1A protein results in increased activity of SOD2 protein] | CTD | PMID:17066447 |
| zinc pyrithione | increases expression | ISO | RGD:730872 | 6480464 | zinc pyrithione results in increased expression of SOD2 mRNA | CTD | PMID:21424779 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of SOD2 mRNA | CTD | PMID:20128680 |
| zinc(0) | decreases activity | EXP | | 6480464 | Zinc results in decreased activity of SOD2 protein | CTD | PMID:22127830 |